Olivier Sitbon
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiology and Cardiovascular Medicine top 0.05%
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Pulmonary Hypertension Research and Treatments 400
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 34
-
- Cardiovascular Issues in Pregnancy 68
- Cardiovascular Function and Risk Factors 33
- Heart Failure Treatment and Management 20
- Co-authors
- Gérald Simonneau (251 shared papers)Marc Humbert (251 shared papers)Xavier Jaïs (214 shared papers)David Montani (196 shared papers)Florence Parent (59 shared papers)Philippe Hervé (36 shared papers)Laurent Savale (176 shared papers)Lewis J. Rubin (43 shared papers)
- Journals
- European Respiratory Journal (70 papers)CHEST Journal (27 papers)The Journal of Heart and Lung Transplantation (22 papers)American Journal of Respiratory and Critical Care Medicine (17 papers)European Respiratory Review (16 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Olivier Sitbon
433 papers receiving 27.4k citations
Olivier Sitbon's Hit Papers
Peers
Comparison fields: 5 of 138
- Pulmonary and Respiratory Medicine 23.6k
- Cardiology and Cardiovascular Medicine 10.4k
- Hepatology 2.8k
- Genetics 3.8k
- Internal Medicine 740
Countries citing papers authored by Olivier Sitbon
This map shows the geographic impact of Olivier Sitbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Sitbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Sitbon more than expected).
Fields of papers citing papers by Olivier Sitbon
This network shows the impact of papers produced by Olivier Sitbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Sitbon. The network helps show where Olivier Sitbon may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivier Sitbon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 468 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pulmonary Arterial Hypertension in France Hit paper breakdown → | 2006 | 1385 |
| 2 | Treatment of Pulmonary Arterial Hypertension Hit paper breakdown → | 2004 | 1279 |
| 3 | Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study Hit paper breakdown → | 2001 | 1134 |
| 4 | Long-term intravenous epoprostenol infusion in primary pulmonary hypertension Hit paper breakdown → | 2002 | 1042 |
| 5 | Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension Hit paper breakdown → | 2013 | 960 |
| 6 | Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension Hit paper breakdown → | 2005 | 808 |
| 7 | Diagnosis and differential assessment of pulmonary arterial hypertension Hit paper breakdown → | 2004 | 734 |
| 8 | Selexipag for the Treatment of Pulmonary Arterial Hypertension Hit paper breakdown → | 2015 | 721 |
| 9 | Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary Hypertension Hit paper breakdown → | 1995 | 624 |
| 10 | Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial Hit paper breakdown → | 2002 | 485 |
| 11 | Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Hit paper breakdown → | 2010 | 474 |
| 12 | Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Hit paper breakdown → | 2017 | 449 |
| 13 | 2009 | 375 | |
| 14 | 2007 | 322 | |
| 15 | 2004 | 320 | |
| 16 | 2013 | 277 | |
| 17 | 2011 | 267 | |
| 18 | 2008 | 263 | |
| 19 | 2016 | 256 | |
| 20 | 2006 | 249 |
About Olivier Sitbon
Olivier Sitbon is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Genetics, Hepatology and Surgery, having authored 468 papers that have together received 28.2k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (400 papers), Cardiovascular Issues in Pregnancy (68 papers), Vascular Anomalies and Treatments (58 papers), Liver Disease and Transplantation (44 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers), Cardiovascular Function and Risk Factors (33 papers), Heart Failure Treatment and Management (20 papers) and Organ Transplantation Techniques and Outcomes (15 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (23.6k citations), Cardiology and Cardiovascular Medicine (10.4k citations), Hepatology (2.8k citations), Genetics (3.8k citations) and Internal Medicine (740 citations). Olivier Sitbon has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Gérald Simonneau, Marc Humbert, Xavier Jaïs, David Montani, Florence Parent, Philippe Hervé, Laurent Savale, Lewis J. Rubin, Richard N. Channick and Victor F. Tapson. Their work appears in journals such as European Respiratory Journal, CHEST Journal, The Journal of Heart and Lung Transplantation, American Journal of Respiratory and Critical Care Medicine and European Respiratory Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.